Results 171 to 180 of about 16,951 (283)

The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study. [PDF]

Life (Basel), 2021
Montero-Vilchez T, Valenzuela-Amigo A, Cuenca-Barrales C, Arias-Santiago S, Leyva-García A, Molina-Leyva A.   +5 more
europepmc   +1 more source

Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIV

Journal of the International AIDS Society, Volume 29, Issue S1, June 2026.
ABSTRACT Introduction Dolutegravir (DTG) is a key antiretroviral (ARV) drug for children living with HIV, but no specific formulation is available for neonates (<28 days old). One of the DTG formulations evaluated in the PETITE‐DTG trial was a novel 5 mg oral DTG dispersible film (DTG‐Film).
Lario Viljoen, Charlene Purdy, Verah Luke, Samantha du Toit, Marisa Groenewald, Lindee Ganger, Anneke C. Hesseling, Anthony J. Garcia‐Prats, Tim R. Cressey, Adrie Bekker   +9 more
wiley   +1 more source

Evaluating E-Visit Utilization and Efficacy for Oral Contraceptive Pills in a Large, Integrated Health Care System. [PDF]

O G Open
Zaritsky E, Sax D, Bolton E, Torres-Rodriguez JM, Bindra AK, Huang J, Reed M.   +6 more
europepmc   +1 more source

Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood. [PDF]

Korean J Fam Med, 2021
Khafagy GM, Shalaby HL, Saad NE, Hasan MD.   +3 more
europepmc   +1 more source

Three papers on side effects and modern contraceptive use among women in Ghana

, 2009
This thesis investigates the issue of side effects and how they may act as a barrier tothe use of modern contraceptive methods among women in Ghana.
Bailey, Claire Elizabeth
core  

Drivers of Vertical HIV Transmission in Sub‐Saharan Africa and the Impact and Cost‐Effectiveness of Targeted and Universal Lenacapavir Pre‐Exposure Prophylaxis

Journal of the International AIDS Society, Volume 29, Issue S1, June 2026.
ABSTRACT Introduction Eliminating vertical HIV transmission remains a major public health priority, particularly in sub‐Saharan Africa (SSA), which accounted for 83% of global paediatric HIV acquistions in 2024. Despite expanded antiretroviral therapy (ART) coverage, gaps in maternal ART access, retention and HIV acquisition during pregnancy and ...
Anna Yakusik, Magdalene K. Walters, Deepak Mattur, Savvy Brar, Leigh F. Johnson, Gesine Meyer‐Rath, Lise Jamieson, Angela Mushavi, John Stover, Mary Mahy   +9 more
wiley   +1 more source

The Association Between Estrogen-Containing Oral Contraceptive Pills and Hypothyroidism. [PDF]

Int J Endocrinol
Alkahlout L, Hamran S, Darwish N, Dweidri Y, Babu GR, Al Saady RM.   +5 more
europepmc   +1 more source

Carpal tunnel syndrome ascribed to low-dose combined oral contraceptive pills.

Indian J Pharmacol, 2023
Yedla D, Vijayan S, Babu TA.
europepmc   +1 more source

Knowledge of Reproductive Age Women About Oral Contraceptive Pills in Al-Qunfudah, Saudi Arabia. [PDF]

Open Access J Contracept, 2022
Al Basri SF, Al Abdali JA, Alzubaidi HM, Almarhabi AA, Alzubaidi MA, Al Qarni G, Alzubaidi NY, Aldabli A, AlMagaadi A, Alamri LA, AlQarni GS, AlAbdli AH, AlGhamdi BH, AlNashri ZA.   +13 more
europepmc   +1 more source

Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review

JEADV Clinical Practice, Volume 5, Issue 2, Page 627-631, June 2026.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin, Tracey Brown‐Maher, Hélène Veillette, David O. Croitoru, Kyle Cullingham   +4 more
wiley   +1 more source